![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 30, 23146-23153, July 28, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
From the
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama 35294 and the
¶ Department of Biochemistry, University of Connecticut Health
Center, Farmington, Connecticut 06030
Received for publication, March 26, 2000, and in revised form, April 7, 2000
| |
ABSTRACT |
|---|
|
|
|---|
The structure of the complex between the
2,3-diphosphoglycerate-independent phosphoglycerate mutase (iPGM) from
Bacillus stearothermophilus and its
3-phosphoglycerate substrate has recently been solved, and
analysis of this structure allowed formulation of a mechanism for iPGM
catalysis. In order to obtain further evidence for this mechanism, we
have solved the structure of this iPGM complexed with
2-phosphoglycerate and two Mn2+ ions at 1.7-Å resolution.
The structure consists of two different domains connected by two loops
and interacting through a network of hydrogen bonds. This structure is
consistent with the proposed mechanism for iPGM catalysis, with the two
main steps in catalysis being a phosphatase reaction removing the
phosphate from 2- or 3-phosphoglycerate, generating an enzyme-bound
phosphoserine intermediate, followed by a phosphotransferase reaction
as the phosphate is transferred from the enzyme back to the glycerate
moiety. The structure also allowed the assignment of the function of
the two domains of the enzyme, one of which participates in the
phosphatase reaction and formation of the phosphoserine enzyme
intermediate, with the other involved in the phosphotransferase
reaction regenerating phosphoglycerate. Significant structural
similarity has also been found between the active site of the iPGM
domain catalyzing the phosphatase reaction and Escherichia
coli alkaline phosphatase.
Phosphoglycerate mutases
(PGMs)1 catalyze three types
of reactions including interconversion of 1,3-phosphoglycerate and
2,3-phosphoglycerate (23PGA) and of 3-phosphoglycerate (3PGA) and
2-phosphoglycerate (2PGA) as well as synthesis of 3PGA from 23PGA (1).
There are two distinct types of PGMs, bisphosphoglycerate mutase
and monophosphoglycerate mutase, and only the first type has the
ability to perform all of the reactions listed above, while
monophosphoglycerate mutases catalyze primarily the interconversion of
3PGA and 2PGA in both glycolysis and gluconeogenesis. There are also
two classes of monophosphoglycerate mutases that are distinguished by
their requirement for 23PGA for catalysis (1, 2). The PGMs requiring
23PGA for catalysis are termed 23PGA-dependent and are the
predominant PGM in mammals, yeast, and some bacteria. They also have
the ability to perform all reactions noted above but at significantly
different rates. The monophosphoglycerate mutases that do not require
DPG for catalysis are termed 23PGA-independent (iPGMs) and are the predominant PGM in plants and some other bacteria, including
endospore-forming Gram-positive bacteria and their close relatives;
iPGMs, unlike cofactor-dependent phosphoglycerate mutases
and bisphosphoglycerate mutases, can only carry out the interconversion
of 2PGA and 3PGA (1, 3, 4). The two classes of monophosphoglycerate
mutases are extremely different in amino acid sequence, catalytic
mechanism, and structure, both tertiary and quaternary. Despite the
differences between these two types of PGMs, the iPGMs all have very
conserved amino acid sequences, as do the
cofactor-dependent phosphoglycerate mutases; the
cofactor-dependent phosphoglycerate mutases are also very
similar in sequence to bisphosphoglycerate mutases, reflecting their
likely similarity in structure and in function (1, 5). Another
difference between the cofactor-dependent phosphoglycerate mutases and iPGMs is that there is no metal ion requirement for catalysis by cofactor-dependent phosphoglycerate mutases
(or bisphosphoglycerate mutases), while at least some iPGMs, including
the enzymes of endospore-forming bacteria, have an absolute and
specific requirement for Mn2+ ions for catalysis, which
makes the activity of these enzymes exquisitely sensitive to pH (1, 4,
6-8). This pH sensitivity is physiologically relevant, since it allows
for the regulation of iPGM activity during different parts of the
developmental cycle of these organisms. During sporulation, the pH in
the developing spore falls to ~6.5, which decreases the activity of
this cell's iPGM, allowing for accumulation of 3PGA, which is stored
in the dormant spore; this 3PGA is then utilized for ATP synthesis
during spore germination, when the pH in the germinating spore rapidly rises to 7.5-8 (9-12). The iPGMs of non-spore-forming organisms that
are closely related to spore formers also require Mn2+ for
catalysis, suggesting that all iPGMs are related evolutionarily to an
ancestral metal ion-requiring iPGM (4). However, the iPGMs of some
organisms (e.g. Escherichia coli, whose iPGM
contains Mn2+ (2), and plants for which the
Mn2+ requirement is not yet clear) may have lost the
extreme pH sensitivity of their enzyme activity during evolution (13),
since this pH dependence may have no physiological importance.
The structure and general mechanism of catalysis of
cofactor-dependent phosphoglycerate mutases were
established a number of years ago (1, 14), but until recently there was
no corresponding information on iPGMs, although over 20 years ago
crystals were obtained of at least one iPGM that might have allowed
structural studies using x-ray crystallography (see appendix of Ref.
15). However, the structure of Bacillus
stearothermophilus iPGM complexed with its 3PGA substrate as well
as with two Mn2+ ions was recently solved by x-ray
crystallography at 1.9-Å resolution (5). Analysis of this structure
located the two Mn2+ ions and the 3PGA in the enzyme's
active site and allowed formulation of a likely catalytic mechanism
that utilizes a phosphoserine-enzyme intermediate. In addition to
information obtained by analysis of the structure of the 3PGA-iPGM
complex, the proposed mechanism was also consistent with the effects on
enzyme activity of a number of site-directed mutations altering
residues in or near the active site. However, another important source
of information on which the proposed catalytic mechanism was based were
studies in which the 2PGA substrate/product was modeled in the active
site of the enzyme. Since the latter information was obtained only from
modeling studies, we decided to obtain further information relevant to our understanding of the mechanism for this iPGM by determining the
crystal structure of B. stearothermophilus iPGM complexed with 2PGA. With this latter information, there will be two structures available, which have both substrates/products bound in the active site
of this iPGM, thus closing the catalytic cycle originating with 3PGA
and finishing with 2PGA or vice versa. The availability of
the structural details of 2PGA binding in the active site of the
enzyme, in contrast to the modeled information previously available,
further allowed definitive assignment of specific mechanistic functions
to different parts of the enzyme.
Since previous work had indicated that there is some limited sequence
similarity between the metal binding regions of E. coli alkaline phosphatase (AP) and iPGMs
(16),2 we also manually
compared the structure of the active site of B. stearothermophilus iPGM with that of the active site of E. coli AP and have found striking structural similarity, but limited only to these regions of the two proteins. Since the catalytic mechanism for E. coli AP has been studied in great detail
(18-19), the similarity in the part of the active site structure
between AP and iPGM is discussed in view of the mechanism proposed for iPGMs.
Crystallization and X-ray Data Collection--
B.
stearothermophilus iPGM was obtained as described previously (20).
The enzyme was dialyzed against 10 mM Hepes-KOH buffer, pH
7.4, 100 mM KCl, 5 mM MnCl2, 1 mM dithiothreitol, 50 µM EDTA and
concentrated to 25 mg/ml. The 2PGA complex with iPGM was crystallized at room temperature using the hanging drop vapor diffusion method (21)
and 24-well Linbro culture plates. The crystallization drops contained
equal volumes (1-2 µl) of the enzyme, 150 mM 2PGA in
water, and the reservoir solution. The drops were equilibrated against
0.3 ml of reservoir solution, which contained 2.1 M
ammonium sulfate and 100 mM sodium citrate, pH 6.7, 25 mM zinc acetate, 20 mM CsCl2, 3%
polyethylene glycol 200, and 1 mM Structure Determination and Refinement--
The space group as
well as the cell parameters for the crystals of the
iPGM·2PGA·Mn2+ complex were isomorphous to those
of the iPGM·3PGA·Mn2+ complex (5, 20), and thus
molecular replacement was not needed for the initial phase
determination. The rigid body refinements (24) of the protein component
of the iPGM·3PGA·Mn2+ complex structure against the
diffraction data set from the iPGM·2PGA·Mn2+ crystals
was sufficient. The Rfree procedure, using a
data set containing 5% of the total unique reflections, was used to
judge the refinement progress (25). The Rcryst
after such refinements decreased to 0.35, whereas the
Rfree was 0.39. After manual inspection and
evaluation of the model using the graphics program QUANTA (26),
adjustments to the protein model were made followed by refinements
using the X-plor least-squares procedures (24), after which the
Rcryst decreased to 0.30. Using the
2Fo Sequence Alignment--
The conserved regions of the B. stearothermophilus iPGM and E. coli AP sequences were
aligned based on the structural alignment of the active site residues
of both enzymes. All manipulations as well as a least-squares
refinement of the structure-based alignment were performed using the
graphics program O (29). All 14 segments encompassing 149 amino acid
residues were superimposed with a root mean square deviation of 1.67 Å. However, all sequence-based alignment methods that were tried
failed to recognize most of these similarities between these two enzymes.
Structure of the 2PGA·iPGM Complex--
The crystal structure of
the B. stearothermophilus iPGM·2PGA complex was solved at
1.7-Å resolution using the structure of the iPGM·3PGA complex as a
model (5, 20). The iPGM·2PGA structure consists of residues from
Lys3 to Val510, two Mn2+ ions,
2PGA, and 172 water molecules (Fig. 1).
Ser2 and the last residue, Lys511, were not
included in the final model due to the lack of their corresponding
electron density. The Ramachandran plot analysis (27) showed no
residues, even in loop areas, in the energetically disallowed
regions. The final refinement statistics are provided in Table
I.
As found previously for the iPGM·3PGA·Mn2+ complex, the
B. stearothermophilus iPGM·2PGA·Mn2+ complex
assumes a compact, globular shape with two domains, A (Lys3-Ala71 and
Thr316-Val510) and B
(Leu79-Tyr305). Both domains have similar
folds consisting of a central eight-stranded Active Site Environment--
The active site is well defined and
is composed of 15 amino acid residues interacting with 2PGA, Mn1, or
Mn2 (Fig. 2A). The amino acid
residues originate from both domains: Asp12,
Ser62, Lys336, Asp403,
His407, Asp444, His445,
His462 in domain A and His123,
Arg153, Asp154, Arg185,
Arg191, Arg261, and Arg264 in
domain B (Fig. 2A and Table
II). The residues interacting directly
with Mn1 are Asp403, His407, and
His462 (average Mn1 to ligand distance of 2.17 Å),
and residues interacting directly with Mn2 are Asp12 (both
NE1 and NE2 atoms), Ser62, His444, and
His445 (average Mn2 to ligand distance of 2.37 Å).
Mn1 also interacts with two phosphate oxygen atoms, O1P and O3P, of
2PGA (average distance of 2.46 Å) (Fig. 2A and Table
III). The common coordinating hard
ligands of Mn2+ ions are carboxylates of aspartate residues
and nitrogens of histidines, although other ligands are sometimes
encountered; these include oxygens of serine residues and phosphate
groups on substrates (31, 32). The geometry of ligand coordination to
both Mn2+ ions is distorted square pyramidal, which is
typical for Mn2+ ions (Fig. 2A and Table III)
(32, 33). The apex coordination is occupied by the NE2 nitrogen atom of
His462 for Mn1 and by the OG oxygen atom of
Ser62 for Mn2. Additional interactions that are important
for catalysis (5) are the bidentate interaction of Arg261
with the phosphate group oxygens O2P and O4P (average distance of 2.81 Å) as well as the bidentate interaction of Arg264 with the
substrate carboxyl group (average distance of 2.87 Å) (Table II). The
O3P phosphate group's oxygen atom semibridges the two Mn2+
ions with a Mn2 to O3P distance of 3.33 Å and an O3P to Mn1
distance of 2.32 Å; the Mn1-O3P-Mn2 angle is 134.0° (Fig.
2A, Table III).
Comparison with the Structure of the iPGM·3PGA·Mn2+
Complex--
There are no global differences between the structures of
the iPGM·2PGA complex and the iPGM·3PGA complex; the fold as well as the arrangement of the domains is, as expected, the same (5). The
active site geometry is similar, although there are differences around
the carboxyl end of the 2PGA including the precise positions of
residues Arg153, Arg154, and
Arg185, all from domain B. Mn1 and Mn2 and their ligands as
well as the residues interacting with the phosphate of 2PGA are also in similar positions and possess similar side chain orientation as in the
3PGA complex. As proposed earlier (5), 2PGA is located in the same area
of the enzyme's active site as is 3PGA in the 3PGA·iPGM complex; the
differences are in the positioning and orientation of the glycerate
moiety (Fig. 2B). In general, the position of the phosphate
and carboxyl moieties of 2PGA and 3PGA are the same. The O3 oxygen of
2PGA is placed in proximal position to the O2 atom of 3PGA, and both
atoms point in the direction of Asp154. In the iPGM·2PGA
complex the O3 to OD1 Asp154 distance is 2.62 Å,
while in the 3PGA complex the distance between the corresponding oxygen
atom, O2, and OD1 of Asp154 is 2.75 Å. The largest
differences between the 3PGA and 2PGA are in the positions for the C2
(from 3PGA) and C3 (from 2PGA) carbon atoms, which differ by 1.21 Å and 1.31 Å, respectively. Carbon atoms C2 for 2PGA and C3 for 3PGA are
bridging atoms with the phosphate group, and their positions are
displaced only by 0.63 Å, suggesting that the placement of the
phosphate group is very important and is a stringent requirement for
catalysis (Fig. 2B).
Comparison of the iPGM Structure with That of Alkaline
Phosphatase--
Comparison of the amino acid sequences of iPGMs from
different sources, including bacteria (both spore formers and non-spore formers) and plants, has shown that all active site residues are conserved in these enzymes (5). Comparison of iPGM sequences with the
sequences of several members of the alkaline phosphatase family has
also shown that the residues directly involved in metal binding are
also conserved between these two types of enzymes (16).2
Alkaline phosphatases contain two Zn2+ ions, while those
iPGMs in which metal ions have been identified contain Mn2+
ions, with two Mn2+ ions identified in the iPGM of B. stearothermophilus (2, 4, 5, 18).2 It appears that all
iPGMs are likely to be metalloenzymes (34, 35), although the presence
of Zn2+ instead of Mn2+ in some of these
enzymes has not yet been excluded.2
The conservation of metal-binding residues in APs and iPGMs suggested
that there might also be some structural similarities between these two
classes of proteins. However, structural similarity comparisons using
the DALI algorithm (36) of our iPGM structure with structures in the
Protein Data Bank gave relatively low scores, indicating that iPGM has
no significant overall structural similarity to known proteins
including E. coli AP (37, 38) (Fig.
3a). Despite this initial lack
of success, the AP and iPGM structures were aligned manually, focusing
on the metal-binding residues using the graphics software QUANTA (26).
To our surprise, the metal-binding residues aligned very well (Fig. 3,
b and c). In addition, the position of the
phosphate group in the active site of E. coli AP (37) nearly
overlaps with that of the phosphate group of the 2PGA bound to B. stearothermophilus iPGM, and the residue in AP that is
phosphorylated during the reaction (Ser102) is also present
in a similar location in iPGM (Ser62). In AP, this Ser
residue is part of a triad,
Asp101-Ser102-Glu103, which is
conserved in all APs; a similar triad,
Asn61-Ser62-Glu63, is also
conserved among all iPGMs (5, 16).
Both iPGM and AP are Catalytic Mechanisms of E. coli AP and B. stearothermophilus
iPGM--
The structural similarity between the metal binding regions
of the active sites of E. coli AP and B. stearothermophilus iPGM suggested that the reaction mechanisms of
these two enzymes would also be similar. E. coli AP is a
phospomonoesterase, although it can catalyze a phosphotransferase
reaction under some conditions, and the catalytic mechanism of this
enzyme is well established (18). The active site of the enzyme contains
two Zn2+ ions and one Mg2+ ion, although the
latter ion does not seem to have any role in catalysis (Fig.
3b) (18, 37). Asp327 (bidentate ligand),
His331, His412, and one of the phosphate oxygen
atoms of AP coordinate with Zn1; Asp51, Asp369,
Asp370, and another oxygen atom of the phosphate coordinate
with Zn2, forming a phosphate bridge between Zn1 and Zn2. An arginine
residue, Arg166, forms a bidentate hydrogen bond with the
remaining two phosphate oxygen atoms. The catalytic Ser102
initially coordinates with Zn2, and catalysis has been proposed to
involve an intermediate five-coordinate phosphate group with trigonal bipyramidal geometry. The fifth position is occupied initially
by Ser102 coordinating with the phosphate, and this is
replaced with a water molecule later in the reaction. Throughout
catalysis, the bidentate interaction between the phosphate oxygen atoms
and Arg166 is maintained and contributes to the known
retention of phosphate configuration (39). Upon phosphorylation of the
active site Ser102 residue, the tetrahedral environment of
the phosphorus atom becomes trigonal bipyramidal. In the
enzyme-substrate complex, one of the phosphate oxygen atoms coordinates
with both metal ions by forming a µ-bridge.
A catalytic mechanism for iPGMs has been proposed based on the
structure of the B. stearothermophilus iPGM-3PGA complex and studies modeling 2PGA in the iPGM active site; results from
site-directed mutagenesis studies were consistent with this mechanism
(5). The analysis of the structure of the iPGM·2PGA complex supports this proposed mechanism, which had initially relied on structural information for the iPGM·2PGA complex obtained by modeling and energetic refinement methods. One important piece of new information provided in the structure of the iPGM·2PGA complex is that, as predicted, the glycerate moiety does not have to move significantly to
allow for catalysis (Fig. 2B). The glycerate parts of both 2- and 3PGA occupy exactly the same space in the active site; therefore, it is likely that positional isomerization (reorientation of
glycerate without affecting its interaction with Mn1 and the bidentate
interaction of its carboxyl group with the enzyme) of the glycerate,
during which the bidentate interaction of its carboxyl group with
Arg264 as well as the interaction of either O2 (3PGA) or O3
(2PGA) with Mn1 are maintained, can take place. In the conversion of
3PGA to 2PGA, this positional isomerization brings the O2 oxygen ion into close proximity with the phosphate group of the phosphoserine intermediate after the hydrogen of the O2H group is abstracted by
Asp154.
The major intermediates in the proposed catalytic mechanism have been
previously described in detail (5) and are as follows (Figs.
2a and 4). (a) 2PGA
binds in the active site of iPGM, during which the phosphate oxygen
atoms O1P and O3P coordinate to Mn1; the two remaining phosphate oxygen
atoms, O2P and O4P, coordinate with Arg261 in a bidentate
fashion. Ser62 coordinates with Mn2 and the O2P oxygen atom
of the phosphate group, and the phosphorus atom is 3.18 Å from the OG
oxygen atom of Ser62 (Fig. 4B, Table II).
(b) Ser62 moves to occupy the fifth coordination
site of the phosphorus atom, which temporarily has a trigonal
bipyramidal geometry. This results in the formation of a phosphoserine
intermediate with breakage of the bond between the phosphate and the
glycerate part of the substrate. During this event, the phosphate group
maintains its bidentate interaction with Arg261, and the
carboxyl group of glycerate maintains its bidentate interaction with
Arg264 (Fig. 4B). (c) The newly
formed negatively charged oxygen atom, O2, of the glycerate coordinates
with Mn1, and Asp154 abstracts a proton from the O3 oxygen
atom of the glycerate. The glycerate undergoes repositioning
(positional isomerization), which brings the O3 oxygen atom close to
the phosphorus atom (Fig. 4C). (d) The
repositioned O3 oxygen occupies the position of the previous
phosphomonoester oxygen of the substrate and interacts with the
phosphoserine intermediate, which again generates a trigonal bipyramidal phosphate group; this leads to breaking of the
phosphoserine ester bond and transfer of the phosphate group to the O3
oxygen of the glycerate. The newly formed 3PGA then moves away from
Ser62, which remains coordinated with Mn2 (as it likely was
during the whole catalytic process) (Fig. 4D).
(e) Finally, the 3PGA·iPGM complex dissociates into enzyme
and 3PGA with the help of the ordered active site water molecule,
Wat63, which is polarized by Mn1 into OH Different Roles of Domains A and B in Catalysis--
As described
above, the iPGM reaction has two main steps, the first being a
phosphatase activity generating a phosphoserine intermediate and the
second being a phosphotransferase reaction including positional
isomerization of the glycerate moiety and transfer of the phosphate
from the phosphoserine back to the glycerate. Based on the iPGM
structures with either 3PGA (5) or 2PGA (this work), it can be seen
that domain B is primarily involved in the phosphotransferase step of
the reaction (note that domain B residues are not involved in
Mn2+ binding) (Fig. 2A). In contrast, the
first step of the reaction, the phosphatase activity, which removes the
phosphate group from the phosphoglycerate and transfers it to
Ser62, utilizes primarily amino acid residues interacting
with both Mn2+ ions, all of which reside in domain A, as is
also the case for AP. Indeed, only the structure of domain A's part of
iPGM's active site is structurally similar to the AP active site.
During the course of iPGM catalysis, Mn1 coordinates with the O2 atom
(previously O1P) of the glycerate part of 2PGA. This interaction has a
dual function; it assists with movement of O1P (O2) away from the
phosphate group of the phosphoserine intermediate, and it also assists
in the proper repositioning of the glycerate part of the substrate by
maintaining the Mn1-O2 interaction. This interaction, together with the
bidentate interaction with the glycerate's carboxyl group, properly
positions the glycerate and its O3 oxygen for nucleophilic attack on
the phosphorus of the phosphoserine intermediate.
The primary residues in domain B interacting with the substrate are
Asp154 (hydrogen removal from the O3-H group of the
glycerate), Arg264 (maintenance of the bidentate
interaction with glycerate's carboxyl group), and Arg261
(bidentate positioning and maintenance of the configuration of the
phosphate group). There is no structural similarity between this domain
and any part of AP. However, Arg261 of iPGM has a
corresponding residue in AP, Arg166, which also maintains a
bidentate interaction with the phosphate in the AP active site (37)
(Fig. 3, b and c).
Activity of the Enzyme in the Crystallization Conditions--
The
free energy change,
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-mercaptoethanol. Diffraction quality crystals were obtained in less than a week, and
they diffracted x-rays to 1.7-Å resolution; the presence of 2PGA was
essential for crystallization. For the diffraction experiments, the
crystals were cryoprotected using 23% ethylene glycol (v/v), 2.5 M ammonium sulfate, and 100 mM sodium citrate,
pH 6.7, and flash frozen at
170 °C in a nitrogen stream using a
Cryostream Cooler (Oxford Cryosystems, Oxford, UK). The x-ray
diffraction data were collected at the Argonne National Laboratory,
Advanced Photon Source, beamline 19-ID of the Structural Biology Center at an x-ray wavelength of 1.1 Å, and a 1.7-Å resolution diffraction data set was obtained. The data were processed and scaled using the
HKL2000 package (22). The unit cell of the crystals was determined to
be as follows: a = 58.41 Å, b = 205.69 Å, c = 123.71 Å with the orthorhombic space group
C2221. The crystal volume per unit of molecular weight was
consistent with one molecule of the enzyme in the asymmetric unit and a
solvent content of 63% (23).
Fc and
Fo
Fc electron density maps, the geometry of the structure was reexamined using a Ramachandran plot
(27), and the model was corrected manually as above. The bulk solvent
correction and the overall B-factor corrections were then
applied to the data during the subsequent structure refinement using
the molecular dynamics procedures of the X-plor protocol (24). Two
Mn2+ ions were located between the two domains of the
structure using [vert]Fo
Fc[vert] electron density maps with a 6
cut-off. The simulated annealing omit maps (25) calculated in the
region where the 2PGA was expected to bind (5) were used to examine as
well as to locate and place the 2PGA in the enzyme's active site. The
topology and parameter files for 2PGA were generated using standard
files based on the energetically expected values for the distances and
angles between atoms of 2PGA provided in the Quanta program (26).
Subsequently, another round of least-squares and molecular dynamics
refinements was performed followed by individual B-factor
refinements (25). Solvent molecules were added to the model based on
the inspection of the 3
level [vert]Fo
Fc[vert] map and the analysis of the contacts with
either the protein or with the 2PGA. The stereochemistry of the model
examined using the Ramachandran plot (27) does not contain any residues
outside of the energetically allowed areas. Figures were drawn using
Ribbons software (28).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (65K):
[in a new window]
Fig. 1.
Ribbon drawing of the B. stearothermophilus iPGM·2PGA·Mn2+
complex. The Mn2+ ions and the 2PGA are shown in a
ball and stick fashion. Domains A and
B as well as their connecting loops are marked.
Crystallographic refinement statistics of B. stearothermophilus iPGM
complexed with 2PGA and Mn2+ ions
-sheet structure
flanked by
-helices, eight in domain A and nine in domain B. Overall, this iPGM assumes an
/
type structure (5, 30). Both
domains have complementary surfaces, and they interact through a
network of hydrogen bond interactions and are connected by two loops,
Gly72-Ser78 and
Val306-Asn315. There is a well defined
solvent-, metal ion-, and substrate accessible cleft between the
two domains. The sides of this cleft are lined by residues primarily
from the loops connecting
-helices and
-strands of both domains.
Both Mn2+ ions, Mn1 and Mn2, and 2PGA are located in this
cleft (Fig. 1). The phosphate of 2PGA and both Mn1 and Mn2 interact
with residues of domain A, and the phosphate interacts only with
Arg261 from domain A, while the glycerate end of the
substrate interacts with residues only from domain B. Both
Mn2+ binding sites are located in a crevice between strands
of domain A. The ordered water molecules are located either on the
enzyme's surface or inside the interdomain cleft.

View larger version (20K):
[in a new window]
Fig. 2.
A, a stereo view of the active site
residues plus the 2PGA and Mn2+ ions. A total of 15 residues constitute the active site of iPGM. B, the
superposition of 2PGA and 3PGA structures based on the x-ray structures
of their respective complexes with iPGM. One-letter amino acid codes
are shown.
Interactions in the active site of B. stearothermophilus iPGM
Coordination of Mn2+ ions in the iPGM · 2PGA complex

View larger version (46K):
[in a new window]
Fig. 3.
Comparison of the structures of all of
(a) or the active sites of (b)
B. stearothermophilus iPGM (green)
and E. coli AP (red) (Protein Data
Bank code 1ALK) or the amino acid sequences of B. stearothermophilus iPGM and E. coli AP
(c). In a, the domains were aligned
based only on the C
backbone atoms of the central
-sheet regions
of both enzymes using the least-squares procedures implemented in the
program O (29). In b, the active sites were aligned
based on the coordinates of corresponding resides from both active
sites. In c, the sequences were aligned based on the
three-dimensional structural alignment of both enzymes, with iPGM
sequences on top and AP sequences on the bottom. Only sequence segments
with good structural overlap are shown. The metal-binding active site
residues, the catalytic triad,
Asn61-Ser62-Glu63, as well as the
Arg261 residue maintaining the bidentate interaction with
the phosphate group are colored in red. Other identical
aligned residues are highlighted in yellow.
/
proteins, although AP is a homodimer. The
monomers of each protein consist of a central
-sheet surrounded by
-helices. When the AP backbone is superimposed on domain A of our
iPGM structure (where the metal binding residues reside), the central
-sheet and the surrounding
-helices superimpose with a
significant degree of overlap (Fig. 3a). However, the areas far from the central
-sheet of both AP and iPGM overlap poorly if at
all, and the structural similarity between these two proteins was
significant only in the active sites and the metal binding regions
(Fig. 3b).
and
H+. The Wat63 hydroxyl group, OH
, probably
replaces the 3PGA ester oxygen in coordination with the Mn1 ion, and
the remaining H+ neutralizes the charge on the O2 oxygen of
the leaving 3PGA. The OD2 oxygen atom of Asp403 probably
completes the square-pyramidal coordination geometry of Mn1 (Fig.
4E). The exchange of protons with the microenvironment probably completes the cycle; one proton originating with the structured Wat63 molecule leaves with the 3PGA product while the proton
abstracted by Asp153 is exchanged with the water
microenvironment and ultimately returned to the OH
coordinating with Mn1. The reaction in the reverse direction from 3PGA
to 2PGA is equally probable.

View larger version (15K):
[in a new window]
Fig. 4.
The proposed catalytic mechanism for
B. stearothermophilus iPGM. Catalysis consists of
both phosphatase and a phosphotransferase component. The major
intermediates in the proposed mechanism for conversion of 2PGA to 3PGA
are binding of 2PGA in the active site (rendition based on the x-ray
coordinates) (A); formation of a phosphoserine intermediate
(phosphatase component) (B); repositioning of the glycerate
moiety (C); transfer of the phosphate group from the serine
residue to the repositioned glycerate to form 3PGA (phosphotransferase
component) (3PGA complex rendition is based on the x-ray coordinates)
(D); and dissociation of 3PGA from the enzyme
(E).
G0, for the reaction
catalyzed by PGM is ~+4.7 kJ/mol (40), although this value can vary
somewhat depending on the reaction conditions. Using this value of
G0, the equilibrium constant for 3PGA
conversion to 2PGA is ~0.15, indicating that 2PGA mixed with PGM
should be largely converted to 3PGA. However, in our crystallization
conditions for the iPGM·2PGA complex, we saw only 2PGA in the
enzyme's active site; we also saw only 3PGA in the active site of the
crystals of the iPGM·3PGA complex (5). The reason for these latter
findings appears to be the inactivity of the enzyme under the
crystallization conditions, since this was less than 0.01% of maximum
activity (data not shown). The reasons for enzyme inactivity are not
clear, but probably include the crystallization temperature (B. stearothermophilus iPGM has maximum activity at 65 °C),
the low pH (4), and the presence of a variety of salts including
Zn2+ ions, which inhibit
iPGM.3 However, the presence
of Mn2+ but not Zn2+ ions in the iPGM active
site was clearly established based on the crystallographic analyses and
refinements. The square pyramidal coordination geometry of the active
site metal ions is also indicative of the presence of Mn2+,
since Zn2+ would have tetrahedral geometry (17).
| |
ACKNOWLEDGEMENT |
|---|
Use of the Argonne National Laboratory Structural Biology Center beamline 19-ID at the Advanced Photon Source is acknowledged for the diffraction data collection.
| |
FOOTNOTES |
|---|
* This work was supported in part by a supplement to National Institutes of Health Grant GM19698 (to P. S.) for the determination of high resolution structures (to P. S. and M. J. J.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 2ejj) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§ To whom correspondence should be addressed: Dept. of Microbiology, University of Alabama at Birmingham, 933 19th St. S., CHSB-19 Rm. 545, Birmingham, AL 35294-2041. Tel.: 205-975-7627; Fax: 205-975-5424; E-mail: jedrzejas@uab.edu.
Published, JBC Papers in Press, April 10, 2000, DOI 10.1074/jbc.M002544200
2 M. J. Jedrzejas and P. Setlow, submitted for publication.
3 M. Chander and P. Setlow, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PGM, phosphoglycerate mutase; 23PGA, 2,3-phosphoglycerate; AP, alkaline phosphatase; iPGM, cofactor-independent phosphoglycerate mutase; 2PGA, 2-phosphoglycerate, 3PGA, 3-phosphoglycerate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Fothergill-Gilmore, L. A., and Watson, H. C. (1989) Adv. Enzymol. Relat. Areas Mol. Biol. 62, 227-313 |
| 2. | Fraser, H. I., Kratskhelia, M., and White, M. F. (1999) FEBS Lett. 455, 344-348 |
| 3. | Carreras, J., Mezquita, J., Bosch, J., Bartrons, R., and Pons, G. (1982) Comp. Biochem. Physiol. B 71, 591-597 |
| 4. | Chander, M., Setlow, B., and Setlow, P. (1998) Can. J. Microbiol. 44, 759-767 |
| 5. | Jedrzejas, M. J., Chander, M., Setlow, P., and Krishnasamy, G. (2000) EMBO J. 19, 1419-1431 |
| 6. | Kuhn, NJ., Setlow, B., Setlow, P., Cammack, R., and Williams, R. (1995) Arch. Biochem. Biophys. 320, 35-42 |
| 7. | Singh, R. P., and Setlow, P. (1979) J. Bacteriol. 137, 1024-1027 |
| 8. | Watabe, K., and Freese, E. (1979) J. Bacteriol. 137, 773-778 |
| 9. | Magill, N. G., Cowan, A. E., Koppel, D. E., and Setlow, P. (1994) J. Bacteriol. 176, 2252-2258 |
| 10. | Magill, N. G., Cowan, A. E., Leyva-Vazquez, M. A., Brown, M., Koppel, D. E., and Setlow, P. (1996) J. Bacteriol. 178, 2204-2210 |
| 11. | Setlow, P., and Kornberg, A. (1970) J. Biol. Chem. 245, 3637-3644 |
| 12. | Swerdlow, B. M., Setlow, B., and Setlow, P. (1981) J. Bacteriol. 148, 20-29 |
| 13. | Botha, F. C., and Dennis, D. T. (1986) Arch. Biochem. Biophys. 245, 96-103 |
| 14. | Rigden, D. J., Alexeev, D., Phillips, S. E. V., and Fothergill-Gilmore, L. A. (1998) J. Mol. Biol. 276, 449-459 |
| 15. | Gatehouse, J. A., and Knowles, J. R. (1977) Biochemistry 16, 3045-3050 |
| 16. | Galperin, M. Y., Bairoch, A., and Koonin, E. V. (1998) Protein Sci. 7, 1829-1835 |
| 17. | Harding, M. M. (1999) Acta Crystallogr. Sec. D 55, 1432-1443 |
| 18. | Coleman, J. E. (1992) Annu. Rev. Biophys. Biomol. Struct. 21, 441-483 |
| 19. | Stec, B., Hehir, M. J., Brennan, C., Nolte, M., and Kantrowitz, E. R. (1998) J. Mol. Biol. 277, 647-662 |
| 20. | Chander, M., Setlow, P., Lamani, E., and Jedrzejas, M. J. (1999) J. Struct. Biol. 126, 156-165 |
| 21. | McPherson, A. (1999) Crystallization of Biological Molecules , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 22. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 23. | Mathews, B. W. (1968) J. Mol. Biol. 33, 491-497 |
| 24. | Brunger, A. T. (1993) X-plor Version 3.1: A System for X-ray Crystallography and NMR , Yale University Press, New Haven, CT |
| 25. | Brunger, A. T. (1992) Nature 355, 472-475 |
| 26. | Molecular Simulations. (1997) QUANTA , Molecular Simulations Inc., Burlington, MA |
| 27. | Laskowski, R., Macarthur, M., Moss, D., and Thomton, J. (1993) J. Appl. Crystallogr. 26, 283-290 |
| 28. | Carson, M. J. (1987) J. Mol. Graph. 5, 103-106 |
| 29. | Jones, T. A., Zou, J.-T, Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. A 47, 110-119 |
| 30. | Sternberg, M. J. E., Cohen, F. E., Taylor, W. R., and Feldmann, R. J. (1981) Phil. Trans. R. Soc. Lond. B 293, 177-189 |
| 31. | Pearson, R. G. (1963) J. Am. Chem. Soc. 85, 3533-3539 |
| 32. | Christianson, D. W., and Cox, J. D. (1999) Annu. Rev. Biochem. 68, 35-57 |
| 33. | Christianson, D. W. (1997) Prog. Biophys. Mol. Biol. 67, 217-252 |
| 34. | Johnson, M., and Price, N. C. (1988) Biochem. J. 252, 111-117 |
| 35. | Smith, G. C, McWilliams, A. D., and Hans, L. F. (1988) Biochem. Biophys. Res. Commun. 136, 336-340 |
| 36. | Holm, L., and Sander, C. (1994) Proteins 19, 165-173 |
| 37. | Kim, E. E., and Wyckoff, H. W. (1991) J. Mol. Biol. 218, 449-464 |
| 38. | Sowadski, J. M., Handschumacher, M. D., Murthy, M. H. K., Foster, B. A., and Wyckoff, H. W. (1994) J. Mol. Biol. 186, 417-433 |
| 39. | Jones, S. R., Kindman, L. A., and Knowles, J. R. (1978) Nature 275, 564-565 |
| 40. | Voet, D., and Voet, J. G. (1990) Biochemistry , p. 451, John Wiley & Sons, Inc., New York |
This article has been cited by other articles:
![]() |
B. Macek, I. Mijakovic, J. V. Olsen, F. Gnad, C. Kumar, P. R. Jensen, and M. Mann The Serine/Threonine/Tyrosine Phosphoproteome of the Model Bacterium Bacillus subtilis Mol. Cell. Proteomics, April 1, 2007; 6(4): 697 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nukui, L. V. Mello, J. E. Littlejohn, B. Setlow, P. Setlow, K. Kim, T. Leighton, and M. J. Jedrzejas Structure and Molecular Mechanism of Bacillus anthracis Cofactor-Independent Phosphoglycerate Mutase: A Crucial Enzyme for Spores and Growing Cells of Bacillus Species Biophys. J., February 1, 2007; 92(3): 977 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. M. Foster, S. Kumar, M. Fougere, and C. K. S. Carlow Cofactor-independent Phosphoglycerate Mutase Has an Essential Role in Caenorhabditis elegans and Is Conserved in Parasitic Nematodes J. Biol. Chem., August 27, 2004; 279(35): 37185 - 37190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bond, M. F. White, and W. N. Hunter High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase J. Biol. Chem., January 26, 2001; 276(5): 3247 - 3253. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |